You are here:

  1. Home
  2. NICE Guidance
  3. Published Guidance

Eculizumab for treating refractory myasthenia gravis (terminated appraisal)

  • Technology appraisal
  • Reference number: TA636
  • Published:  30 June 2020
  • Guidance
  • Tools and resources
  • History

Tools and resources

Tools to help you put the guidance into practice.

Guidance into practice

  • About the Into practice guide

  • Practical steps to improving the quality of care and services using NICE guidance

Back to top